Opioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulation.
暂无分享,去创建一个
S. Nielsen | N. Hadrup | J. Praetorius | T. Jonassen | D. Kapusta | J. Petersen | E. Meier | M. Graebe | S. Christensen | L. Brønd | D. Staahltoft
[1] S. Nielsen,et al. The Role of Putative Phosphorylation Sites in the Targeting and Shuttling of the Aquaporin-2 Water Channel* , 2002, The Journal of Biological Chemistry.
[2] G. Calo’,et al. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice , 2002, British journal of pharmacology.
[3] A. Vandewalle,et al. Long Term Regulation of Aquaporin-2 Expression in Vasopressin-responsive Renal Collecting Duct Principal Cells* , 2002, The Journal of Biological Chemistry.
[4] S. Nielsen,et al. Losartan treatment normalizes renal sodium and water handling in rats with mild congestive heart failure. , 2002, American journal of physiology. Renal physiology.
[5] J. Frøkiaer,et al. Aquaporins in the kidney: from molecules to medicine. , 2002, Physiological reviews.
[6] J. Verbalis,et al. Vasopressin V2 receptor antagonists. , 2001, Cardiovascular research.
[7] S. Nielsen,et al. Immunocytochemical and immunoelectron microscopic localization of α-, β-, and γ-ENaC in rat kidney , 2001 .
[8] H. Arima,et al. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats. , 2000, Endocrinology.
[9] S. Nielsen,et al. Renal water handling in rats with decompensated liver cirrhosis. , 2000, American journal of physiology. Renal physiology.
[10] D. Kapusta. Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function , 2000, Peptides.
[11] S. Salvadori,et al. Nociceptin/orphanin FQ receptor ligands , 2000, Peptides.
[12] L. Moulédous,et al. Tissue distribution of the opioid receptor-like (ORL1) receptor , 2000, Peptides.
[13] A. Nairn,et al. Prostaglandin E(2) interaction with AVP: effects on AQP2 phosphorylation and distribution. , 2000, American journal of physiology. Renal physiology.
[14] S. Nielsen,et al. Decreased vasopressin-mediated renal water reabsorption in rats with chronic aldosterone-receptor blockade. , 2000, American journal of physiology. Renal physiology.
[15] S. Nielsen,et al. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. , 2000, American journal of physiology. Renal physiology.
[16] W. Abraham,et al. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. , 1999, Journal of the American Society of Nephrology : JASN.
[17] G. Dibona,et al. Renal expression of aquaporins in liver cirrhosis induced by chronic common bile duct ligation in rats. , 1999, Journal of the American Society of Nephrology : JASN.
[18] J. K. Chang,et al. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. , 1999, The Journal of pharmacology and experimental therapeutics.
[19] M. Salis,et al. Cardiovascular effects of nociceptin in unanesthetized mice. , 1999, Hypertension.
[20] J. Frøkiaer,et al. Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats. , 1998, The American journal of physiology.
[21] M. Sugimachi,et al. Dynamic sympathetic regulation of left ventricular contractility studied in the isolated canine heart. , 1998, American journal of physiology. Heart and circulatory physiology.
[22] S. Nielsen,et al. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis. , 1998, American journal of physiology. Renal physiology.
[23] J. Frøkiaer,et al. Acute effects of vasopressin V2-receptor antagonist on kidney AQP2 expression and subcellular distribution. , 1998, American journal of physiology. Renal physiology.
[24] I. Abu-Amarah,et al. Renal denervation alters cardiovascular and endocrine responses to hemorrhage in conscious newborn lambs. , 1998, American journal of physiology. Heart and circulatory physiology.
[25] P. Fernández-Llama,et al. Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome. , 1998, Kidney international.
[26] J. Meunier,et al. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. , 1997, European journal of pharmacology.
[27] J. Petersen,et al. Influence of renal nerves and sodium balance on the acute antidiuretic effect of bendroflumethiazide in rats with diabetes insipidus. , 1997, The Journal of pharmacology and experimental therapeutics.
[28] C. Maggi,et al. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. , 1997, European journal of pharmacology.
[29] F. Marumo,et al. Phosphorylation of Serine 256 Is Required for cAMP-dependent Regulatory Exocytosis of the Aquaporin-2 Water Channel* , 1997, The Journal of Biological Chemistry.
[30] J. Frøkiaer,et al. Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Yasui,et al. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. , 1997, The American journal of physiology.
[32] R. Schrier,et al. Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. , 1997, The Journal of clinical investigation.
[33] H. Lippton,et al. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). , 1996, Life sciences.
[34] M. Knepper,et al. Reduced renal medullary water channel expression in puromycin aminonucleoside--induced nephrotic syndrome. , 1997, Journal of the American Society of Nephrology : JASN.
[35] D. G. Shirley,et al. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. , 1997, Nephron.
[36] D. Ausiello,et al. cAMP motifs regulating transcription in the aquaporin 2 gene. , 1996, The American journal of physiology.
[37] D. Grandy,et al. Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.
[38] Marc Parmentier,et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.
[39] S. Nielsen,et al. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. , 1995, The American journal of physiology.
[40] K. Shimizu,et al. Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans. , 1995, Kidney international.
[41] Y. Yamamura,et al. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men. , 1995, The Journal of pharmacology and experimental therapeutics.
[42] S. Nielsen,et al. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Kjaer,et al. Dehydration-induced release of vasopressin involves activation of hypothalamic histaminergic neurons. , 1994, Endocrinology.
[44] J. Plange-Rhule,et al. A novel computer-driven, servo-controlled fluid replacement technique and its application to renal function studies in conscious rats. , 1993, Clinical science.
[45] H. Lam,et al. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy. , 1991, The Journal of pharmacology and experimental therapeutics.
[46] J. Petersen,et al. Superiority of tetraethylammonium to p-aminohippurate as a marker for renal plasma flow during furosemide diuresis. , 1987, Renal physiology.